47 results
424B3
COEP
Coeptis Therapeutics Holdings Inc
26 Mar 24
Prospectus supplement
6:30am
also determines that Mr. Deschamps qualifies as an “audit committee financial expert” as defined in the SEC rules and will satisfy the financial … qualifies as an “audit committee financial expert” as defined in the SEC rules and will satisfy the financial
sophistication requirements of Nasdaq
424B3
COEP
Coeptis Therapeutics Holdings Inc
26 Mar 24
Prospectus supplement
6:30am
committee financial expert” as defined in the SEC rules and will satisfy the financial sophistication requirements of Nasdaq. The Company’s audit committee … of the SEC and rules of Nasdaq. The Company also determines that Mr. Deschamps qualifies as an “audit committee financial expert” as defined
8-K
EX-99.1
COEP
Coeptis Therapeutics Holdings Inc
5 Dec 23
Regulation FD Disclosure
4:30pm
in global supply chain, operations, business development, and procurement Colleen Delaney MD, MSc CSO & CMO World - renowned expert in cell and gene
424B3
i75ml3kvencej4i69
30 Nov 23
Prospectus supplement
5:00pm
8-K
EX-1.1
y8f5zx3f41dahbq
16 Jun 23
Coeptis Therapeutics Holdings, Inc. Announces Pricing of $3.5 Million
5:15pm
424B4
h6tbb jr5p1tv96u
15 Jun 23
Prospectus supplement with pricing info
9:25am
8-K
EX-99.1
gtieeh
5 Jun 23
Regulation FD Disclosure
6:12pm
8-K
bzttufi9od4 uxj9a
3 Nov 22
Index to Financial Statements
4:58pm
424B3
04d7wia b18fwb
30 Sep 22
Prospectus supplement
4:18pm